The mucosal immune system: from fundamental concepts to vaccine development

Vaccine

Volumn 10, Issue 2, 1992, Pages 75-88

  McGhee, Jerry R ^a   Mestecky, Jiri ^a   Dertzbaugh, Mark T ^a   Eldridge, John H ^a   Hirasawa, Masatomo ^a   Kiyono, Hiroshi ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

lamina propria; lymphocytes; Mucosal; Peyer's patches; secretory IgA

Indexed keywords

IMMUNOGLOBULIN A; VACCINE;

HUMAN; LAMINA PROPRIA; LYMPHOCYTE; MUCOSA; NONHUMAN; PEYER PATCH; REVIEW;

ADMINISTRATION, ORAL; ANIMAL; B-LYMPHOCYTES; CYTOKINES; HUMAN; IMMUNE SYSTEM; IMMUNOGLOBULIN A, SECRETORY; MUCOUS MEMBRANE; PLASMA CELLS; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; VACCINES;

EID: 0026579998     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(92)90021-B     Document Type: Review

References (156)

1. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response
2. Regulation of IgA synthesis and immune response by T cells and interleukins
3. The mucosal defence system
4. Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit
5. Repopulation with IgA-containing cells of bronchial and intestinal lamina propria after transfer of homologous Peyer's patches and bronchial lymphocytes
6. A model for local immunity
7. Induction and expression of antibodies in secretions: the ocular immune system
8. A common mucosal immune system revisited
9. Migration of lymphocytes in the mucosal immune system
10. The common mucosal immune system and current strategies for induction of immune responses in external secretions
11. Oral tolerance
12. Bronchus-associated lymphoid tissue
13. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix and Peyer's patches
14. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles
15. The membranous epithelial (M) cell and the mucosal immune system
16. Surface phenotype of Peyer's patches germinal center cells: implications for the role of germinal centers in B-cell differentiation
17. Relationship between expression of IgA by Peyer's patch cells and functional IgA memory cells
18. Gut mucosal immunization with reovirus serotype I/L stimulates virus-specific cytotoxic T cell precursors as well as IgA memory cells in Peyer's patches
19. Research in gastrointestinal immunology
20. CD4-positive, Leu 8-negative helper-inducer T cells predominate in the human intestinal lamina propria
21. Isolation and functional characterization of human mucosal lymphoid cells
22. An embryonic source of Ly1 but not conventional B cells
23. Many of the IgA producing plasma cells in the murine gut are derived from self-replenishing precursors in the peritoneal cavity
24. The Ly-1 B cell lineage
25. Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM autoantibodies
26. Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression
27. Origin of IgA-secreting plasma cells in the mammary gland
28. Evidence for a common mucosal system
29. Immunohistochemical characterization of intracellular J-chain and binding site for secretory component (SC) in human immunoglobulin (Ig)-producing cells
30. The role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man
31. The antigen-specific, major histocompatibility complex-restricted receptor on T cells
32. The biologic roles of CD2, CD4 and CD8 in T-cell activation
33. T-cell regulation of murine IgA synthesis
34. Characteristics and regulatory function of murine Con A-induced, cloned T cells obtained from Peyer's patches and spleen: Mechanisms regulating isotype-specific immunoglobulin production by Peyer's patch B cells
35. Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues
36. IgA responses in xid mice: Oral antigen primes Peyer's patch cells for in vitro immune-responses and secretory antibody production
37. Murine Peyer's patch T-cell clones: Characterization of antigen-specific helper T cells for immunoglobulin A responses
38. Isotype-specificity of helper T-cell clones
39. Two types of mouse helper T-cell clone: Implication for immune regulation
40. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
41. The role of helper T cell products in mouse B cell differentiation and isotype regulation
42. Two types of murine helper T-cell clone
43. Two types of mouse helper T cell clone
44. Analysis of Th1 and Th2 cells in murine gut-associated tissues
45. Detection of individual mouse splenic T cells producing IFN-γ and IL-5 using the enzyme-linked immunospot (ELISPOT) assay
46. Leukocytes in the intestinal epithelium: an unusual immunological compartment
47. Functional characteristics of Peyer's patch cells III
48. Enterically induced immunological tolerance
49. Functional studies of Peyer's patches: Evidence for their participation in intestinal immune responses
50. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes
51. Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production
52. Recombinant murine IL-5 induced high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells
53. Interleukins and IgA synthesis: human and murine IL-6 induce high rate IgA secretion in IgA-committed B cells
54. Interleukin 5 and interleukin 4 produced by Peyer's patch T-cells selectively enhance immunoglobulin A expression
55. A mouse T cell product that preferentially enhances IgA production
56. A mouse T cell product that preferentially enhances IgA production
57. The role of IL-5 in IgA B cell differentiation
58. The effects of IL-4 and IL-5 on the IgA response by murine Peyer's patch B cell subpopulations
59. Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells
60. The mouse gut T lymphocyte, a novel type of T cell
61. Natural killer activity of gut mucosal lymphoid cells in mice
62. Human intestinal mononuclear cells
63. Functional characteristics of lymphocytes isolated from the rat large intestine
64. Cytotoxic T cells in small intestine epithelium, lamina propria and lung lymphocytes
65. Nonspecific recruitment of cytotoxic effector cells in the intestinal mucosa of antigen-primed mice
66. Detection and characterization of cytotoxic T lymphocyte precursors in the murine intraepithelial leukocyte population
67. Murine intestinal intraepithelial lymphocytes
68. Functional characteristics of Peyer's patch lymphoid cells
69. Effects of antigen-feeding on intestinal and systemic immune responses
70. A murine cytotoxic T lymphocyte clone from the intestinal mucosa that is antigen-specific for proliferation and displays broadly reactive inducible cytotoxic activity
71. Spontaneous in vitro evolution of lytic specificity of cytotoxic T lymphocyte clones isolated from murine intestinal epithelium
72. Regulatory function for murine intraepithelial lymphocytes
73. + intraepithelial lymphocytes
74. Intestinal intraepithelial lymphocytes are a distinct set of γδ T cells
75. The response of gut-associated T lymphocytes to intestinal viral immunization
76. Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection
77. Mechanisms of neutralization of animal viruses
78. Mechanism of neutralization of influenza-virus by secretory IgA is different from that of monomeric IgA or IgG
79. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases
80. Mucosal barrier mechanisms
81. Oral immunization and secretory immunity to viruses
82. The role of mononuclear phagocytes in HTLV-III/LAV infection
83. Host defenses against influenza: The role of antihemagglutinin antibody
84. Quantitative relationships between an influenza virus and neutralizing antibody
85. Interaction of neutralized influenza virus with avian and mammalian cells
86. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin
87. Host defenses against adhesion of bacteria to mucosal surfaces
88. Antimicrobial activity of the secretory innate defense factors of lactoferrin, lactoperoxidase and lysozyme
89. Synergism between ecologic and immunologic control mechanisms of intestinal flora
90. Immune response to oral salmonella vaccines
91. Interference of oral immunization with the intestinal absorption of heterologous albumin
92. Intestinal uptake of macromolecules: Effect of oral immunization
93. Milk precipitins, circulating immune complexes and IgA deficiency
94. Effect of locally induced intestinal anaphylaxis on the uptake of a bystander antigen
95. Mucosal penetration of antigen in the presence or absence of serum-derived antibody
96. Inhibition of cutaneous anaphylaxis and Arthus reactions in the mouse by antigen-specific IgA
97. The ability of IgA to inhibit the complement-mediated lysis of target red blood cells sensitized with IgG antibody
98. Cholera toxin and its subunits as potential oral adjuvants
99. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin
100. Oral immunization against cholera
101. Oral immunization with influenza virus: Experimental and clinical studies
102. Antibody in tears saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine
103. Secretory antibody following oral influenza immunization
104. New strategies for oral immunization
105. Immunogenicity of Ty21a attenuated Salmonella typhi given with sodium bicarbonate or in enteric-coated capsules
106. Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice
107. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response
108. Genetics of bacterial enterotoxins
109. Gangliosides and membrane receptors for cholera toxin
110. Cellular kinetics of the intestinal immune response to cholera toxin in rats
111. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen
112. Genetic control of the murine immune response to cholera toxin
113. Ir gene control of the murine secretory IgA response to cholera toxin
114. Determinants of the localization, magnitude and duration of a specific IgA plasma cell response in enterically immunized rats
115. Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin
116. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response
117. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci
118. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit
119. Oral administration of cholera toxin-sendai virus conjugates potentiates gut and respiratory immunity against sendai virus
120. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosa tissues
121. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens
122. Efficacy of inactivated influenza vaccine delivered by oral administration
123. Combined oral/nasal immunization protects mice from Sendai virus infection
124. Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice
125. Cholera toxin as a mucosal adjuvant the effect of H-2 genes
126. Synthesis and characterization of Escherichia coli 018 O-polysaccharide conjugate vaccines
127. Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of a cholera toxin or its B subunit as a carrier bound to high- or lower-molecular weight Vi
128. Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum cirumsporozoites
129. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens
130. Prevention of invasive bacterial diseases by immunization with polysaccharide-protein conjugates
131. Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates
132. Biodegradable microspheres: Vaccine delivery system for oral immunization
133. Immune responses to influenza virus in orally and systemically immunized mice
134. Clinical evaluation of injectable biodegradable contraceptive system
135. Evaluation of a new three-month injectable contraceptive microsphere system in primates
136. Poly (dl-lactide-co-glycolide)/northisterone microcapsules: An injectable biodegradable contraceptive
137. Degradation rates of oral resorbable implants (polylactates and polyglycolates): Rate modification with changes in PLA/PGA copolymer ratios
138. Biodegradable microspheres as a vaccine delivery system
139. Biodegradable and biocompatible poly(dl-lactide-Co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies
140. Controlled vaccine release in the gut-associated lymphoid tissues
141. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response
142. Biodegradable microparticles as controlled release antigen delivery systems
143. Selective delivery of antigens by recombinant bacteria
144. Cloning virulence determinants from Streptococcus mutans and the use of recombinant clones to construct bivalent oral vaccine strains to confer protective immunity against S. mutans-induced dental caries
145. Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein
146. Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis
147. Expression of hepatitis-B virus antigens in attenuated Salmonella for oral immunization
148. Expression of the envelope antigens of dengue virus in vaccine strains of Salmonella
149. Preliminary studies on infection by attenuated Salmonella in guinea pig and on expression of herpes simplex virus
150. Synthesis of the surface glycoprotein of rotavirus SA11 in the aroA strain of Salmonella typhimurium SL3261
151. Hybrid vaccines using Escherichia coli as an antigen carrier
152. Delivery of the cholera toxin-B subunit by using a recombinant Yersinia enterocolitica strain as a live oral carrier
153. Recombinant BCG as a candidate oral vaccine vector
154. Oral administration of TNP-Lactobacillus conjugates in mice